Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

NCT04029480 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Ertugliflozin 5 mg
DRUG: Ertugliflozin 15 mg
DRUG: Placebo to ertugliflozin 15 mg
DRUG: Placebo to ertugliflozin 5 mg
BIOLOGICAL: Insulin
DRUG: Metformin

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]